Skip to content
Coming soon
  • Agriculture Tech
  • AI Agents & Models
  • Autonomy
  • Avatars & Digital Humans
  • Biotech / Synthetic Biology
  • Blockchain / Crypto
  • Brain-Computer Interfaces
  • Climate Tech
  • Cloud & Edge Computing
  • Commerce
  • Cybersecurity
  • Data Infrastructure
  • Defense
  • Digital Identity
  • Education Tech
  • Energy
  • Fashion & Textiles
  • Food Tech
  • Healthcare Systems
  • Longevity & Human Enhancement
  • Manufacturing
  • Materials Science
  • Mobility
  • Quantum Computing
  • Semiconductors
  • Smart Homes
  • Space Tech
  • Spatial Computing
  • Voice & Conversational Interfaces
  • Wearables
Frontline

05.13.26

Today's lineup

In this edition

  1. 01
    JPMorgan launches second tokenized fund on Ethereum, scaling blockchain from pilot program to operational infrastructure.
  2. 02
    Wrongful-death lawsuit blames ChatGPT for fatal overdose, forcing OpenAI into a policy reckoning on AI liability.
  3. 03
    GitHub Copilot abandons seat licenses for usage-based pricing, signaling AI tooling has reached commodity maturity.
JPMorgan Chase logo

JPMorgan files for second tokenized fund as blockchain infrastructure moves from proof-of-concept to product

The bank's Kinexys unit is launching a new tokenized money-market vehicle on Ethereum, expanding institutional on-chain settlement from pilot to portfolio strategy.

Founded
2000
26 years
Status
Public
JPM
Market cap
$820.9B
Headcount
10k+

The story

JPMorgan filed to launch a second tokenized money-market fund[1] on Ethereum, investing in U.S. Treasuries and repurchase agreements. The move follows the bank's Kinexys (formerly Onyx) platform demonstrating cross-border tokenized Treasury redemptions[2] with Ripple and Mastercard earlier this month, and marks the clearest signal yet that Wall Street's blockchain infrastructure is moving from proof-of-concept to product shelf. The new vehicle will sit alongside the bank's existing JPM Coin deposit token, which already settles over $2 billion in daily institutional payment volume. The market priced the news at +1.63% on the day—muted relative to the structural significance. What changed: institutional tokenization is no longer a settlement experiment confined to interbank rails. The cross-border redemption demo on May 7 proved the plumbing works across chains, counterparties, and jurisdictions. Now JPMorgan is productizing that capability into a fund structure clients can allocate to. This is the inflection point where blockchain moves from back-office efficiency play to front-office distribution channel. The timing matters: Stripe's $1.1B Bridge acquisition and Visa's Tokenized Asset Platform rollout both happened in the past six months. The race is no longer whether to tokenize—it's who controls the issuance rails and captures the settlement spread as assets migrate on-chain. We're watching three signals. First, whether JPMorgan can pull institutional AUM into the tokenized fund at scale—proof that allocators see on-chain settlement as differentiated enough to justify migration cost. Second, how regulators treat these vehicles: are they funds that happen to use blockchain plumbing, or does tokenization trigger new custody, transfer-agent, or cross-border reporting requirements? Third, competitive response from the asset-management complex. If BlackRock, Fidelity, or State Street launch competing tokenized vehicles in the next 90 days, it confirms the distribution thesis. If they don't, it suggests the use case is still confined to JPM's captive institutional client base—a smaller wedge than the market is pricing.

Continue reading

The rest of this story is for subscribers.

Including Our Take, the Tailwinds & headwinds framing, Connections across the FOBI roster, and What should you do.

Founding
50% off
$5
/month
 
94 of 100 spots left
Full
$10
/month
 
Available once all 100 Founding Member spots are claimed.
Get full access

Already subscribed? Sign in →

OpenAI logo

Lawsuit pins teen's death on ChatGPT drug advice, forcing safety reckoning at critical policy moment

A wrongful-death suit alleges OpenAI's chatbot gave dangerous drug-combination guidance that led to a teenager's fatal overdose. The case arrives as regulators worldwide are finalizing AI liability frameworks—and OpenAI scales voice APIs into customer-service layers where guardrails matter most.

Founded
2015
11 years
Status
Private
Total raised
$289.7B
Headcount
5k-10k

The story

A family alleges in court that ChatGPT provided fatal drug-combination advice to their teenager[1], a claim that transforms the AI-liability landscape from theoretical to concrete. The chatbot reportedly assured the user that a specific mixture of substances was safe; toxicology later confirmed it was lethal. OpenAI did not prompt the user toward medical professionals, did not flag substance-abuse hotlines, and did not surface obvious warning signals. The case hinges on duty of care: did OpenAI's design, instruction-tuning, and deployment safeguards fall below a reasonable standard for a system it knew would be asked to answer health and safety questions? This lawsuit lands at a pivot point in OpenAI's product architecture. Two weeks ago, OpenAI launched GPT-Realtime-2 voice APIs[2] optimized for customer-service integration—bank chat, insurance claims, school counseling systems. Voice creates immediacy and intimacy; users treat voice outputs differently than text, trusting them more readily and acting on them faster. When ChatGPT moves from chat.openai.com (where users expect entertainment and rough-draft thinking) into a school nurse's intake system or a financial-distress hotline (where users expect medical or expert judgment), the liability posture shifts. A jury may argue OpenAI had duty to implement guardrails proportional to the decision's stakes. Today, OpenAI does not mandate different safety profiles for different deployment contexts; a single model drives all uses. That architecture—one capability, many risk contexts—is now under scrutiny. The second signal to track is regulatory response. The EU's AI Act, now in enforcement phase, imposes strict liability on "high-risk" systems including health and substance-abuse advisory. The US FDA is moving toward pre-market review of clinical-decision-support AI. This lawsuit, if it survives summary judgment, will shape how courts interpret "foreseeability" of harm and "design defect" in AI products. OpenAI's legal team will argue the user made an autonomous choice; the plaintiff's team will argue the chatbot's training deliberately optimized persuasiveness and did not anticipate or prevent misuse in high-stakes health contexts. The precedent that emerges—whether liability attaches to the designer, the deployer, or the end-user system integrator—will reset insurance, indemnification, and product-development roadmaps across the sector.

Continue reading

The rest of this story is for subscribers.

Including Our Take, the Tailwinds & headwinds framing, Connections across the FOBI roster, and What should you do.

Founding
50% off
$5
/month
 
94 of 100 spots left
Full
$10
/month
 
Available once all 100 Founding Member spots are claimed.
Get full access

Already subscribed? Sign in →

GitHub logo

GitHub Copilot shifts to usage-based pricing, signaling AI coding tool monetization maturity

The move from fixed-seat subscriptions to flex allotments and a new Max plan reveals GitHub's confidence in Copilot's stickiness—and previews how the entire developer-tools industry will price AI agent capacity as adoption scales.

Founded
2008
18 years
Status
Acquired
MSFT
Market cap
$3109.3B
Headcount
1k-5k

The story

GitHub unveiled flex allotments and a new Max plan for Copilot individual subscriptions[1], replacing simple per-seat pricing with a usage-based model. Pro users get a monthly token or request budget; Pro+ users get more generous allotments; Max is a new tier targeting power users who exhaust higher budgets. The move surfaces a critical inflection point: Copilot is no longer a "nice-to-have" productivity marginal at the editor toolbar. It's a core dependency in the development workflow, and GitHub is confident enough in that stickiness to bet on extracting margin from consumption rather than fighting for marginal seat growth. This matters because it exposes the real competitive battleground in AI coding tools. Incumbent incumbents like JetBrains and Amazon Q Developer now have a pricing road map to follow—and a set of conversion targets to hit. Meanwhile, open-weight models from Meta and Mistral AI present an asymmetric pressure: enterprises can self-host and avoid usage metering altogether. GitHub's shift assumes most developers will tolerate or even prefer the pricing friction of flex budgets (it creates natural rate-limiting) in exchange for seamless integration and Copilot's superior model performance. That assumption holds as long as OpenAI's models stay ahead of open-weight alternatives. If Claude Code or Codestral narrow that gap further, usage-based pricing becomes a liability—a switching cost that favors open-source or on-premise deployments. Watch the next signal: which customer cohorts upgrade to Max, and at what monthly bill. GitHub's own usage metrics (tokens per request, agents-per-month) will reveal whether power users are already hitting pro-rata limits or if Max is pure margin expansion in a largely fixed-user pool. The real pressure test comes in Q3 when enterprises integrate agents into CI/CD pipelines, where token burn is predictable and measurable. If those buyers start building token budgets into their CapEx and negotiate annual contracts, pricing moves from individual angling into enterprise deal structures—and that's when the real competitive separation happens.

Continue reading

The rest of this story is for subscribers.

Including Our Take, the Tailwinds & headwinds framing, Connections across the FOBI roster, and What should you do.

Founding
50% off
$5
/month
 
94 of 100 spots left
Full
$10
/month
 
Available once all 100 Founding Member spots are claimed.
Get full access

Already subscribed? Sign in →